Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Overactive Bladder Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)
- Report Code : TIPRE00004082
- Pages : 209
The global overactive bladder treatment market is expected to grow from US$ 4,295.93 million in 2021 to US$ 5,333.92 million by 2028. It is estimated to grow at a CAGR of 3.1% from 2022 to 2028.
Overactive bladder (OAB) is the frequent and sudden urge to urinate, which might be difficult to control. OAB can be caused due to abdominal trauma, infection, nerve damage, and certain medications. OAB is common in people aged 65 and older. Women may have OAB after 45 years. The treatment includes changing certain behaviors, medications, and nerve stimulation. According to the National Association for Incontinence data, in 2018, ~200 million people worldwide were affected by urinary incontinence. Stress incontinence and urge incontinence are the two common types of urinary incontinence affecting women, wherein the latter is also known as overactive bladder.
Similarly, a study conducted by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020 stated that urinary tract infection (UTI) was the cause of ~6 million physician visits each year in the US. In Canada, ~500,000 visits to the doctor’s office are for UTI consultations annually. UTI is the eighth and fifth most common reason for ambulatory clinic visits and emergency department visits, respectively, in the country. Thus, increasing prevalence of urinary incontinence and growing incidence of urinary tract infections are driving the overactive bladder treatment market.
The overactive bladder treatment market is segmented into pharmacotherapy, disease type, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The overactive bladder treatment market report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, market dynamics, and the competitive analysis of the globally leading market players.
Based on pharmacotherapy, the overactive bladder treatment market is segmented into mirabegron, Botox, neurostimulation, anticholinergics, and intravesical instillation. The mirabegron segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR during the forecast period. Mirabegron is used alone or with solifenacin to treat overactive bladder in adults. It is used to treat neurogenic detrusor overactivity (a bladder control condition caused by the brain, spinal cord, or nerve problem) in children aged three years or more. Mirabegron belongs to the class of drugs called beta-3 adrenergic agonists. It relaxes the bladder muscles to prevent urgent, frequent, or uncontrolled urination. Mirabegron is available as an extended-release (long-acting) tablet and an extended-release suspension that can be taken orally. In October 2022, Zydus Pharmaceuticals Inc. received approval from the USFDA to market Mirabegron Extended-Release Tablets USP 25 mg and 50 mg.
The COVID-19 pandemic has shown some favorable scenarios for players operating in the overactive bladder treatment market. The US was the highly affected country in North America. The infection severely affected the geriatric population in the country, causing various complications and leading to the death of a large population. For instance, as of May 16, 2022, the US reported 84,230,829 COVID cases with 1,026,670 deaths. Therefore, overactive bladder treatment and proper care are required to prevent chronic cases of infection and health conditions.
After the COVID-19 outbreak, there has been an increase in the occurrence of OAB. According to a study by American Urological Association, patients with COVID-19 infections were at an increased risk for developing new or worsening overactive bladder symptoms. Moreover, approximately one-third of patients with COVID-19 reported a significant increase in clinical symptoms during the International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB) conducted two months after infection. Out of these one-third of patients, approximately 1 in 5 patients, reported that their OAB symptoms were new. This increased prevalence of OAB due to COVID-19 positively impacted the demand for overactive bladder treatment during the pandemic.
Some of the key primary and secondary sources referred to while preparing the report on the overactive bladder treatment market are the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the Office on Women’s Health—a division of US Department of Health and Human Services, among others.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Overactive Bladder Treatment Market– By Pharmacotherapy
1.3.2 Global Overactive Bladder Treatment Market– By Disease Type
1.3.3 Global Overactive Bladder Treatment Market – By Geography
2. Global Overactive Bladder Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Overactive Bladder Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 South & Central America – PEST Analysis
4.2.5 Middle East & Africa – PEST Analysis
4.3 Expert Opinion
5. Overactive Bladder Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Urinary Incontinence
5.1.2 Growing Incidence of Urinary Tract Infections
5.2 Key Market Restraints
5.2.1 Recalls of Therapeutic Drugs
5.3 Key Market Opportunities
5.3.1 Increasing Number of Mergers and Acquisitions
5.4 Future Trends
5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies
5.5 Impact analysis
6. Global Overactive Bladder Treatment Market – Global Analysis
6.1 Global Overactive Bladder Treatment Market Revenue Forecast and Analysis
6.1.1 Global Overactive Bladder Treatment Market Revenue Forecast and Analysis
6.1.2 Global Overactive Bladder Treatment Market – Market Potential Analysis, By Region
6.1.3 Company Analysis
6.2 Comparative Company Analysis
6.2.1 Growth Strategy Analysis
6.2.2 Market Positioning of Key Players in the Overactive Bladder Treatment Market
6.2.2.1 Astellas Pharma Inc.
6.2.2.2 Allergan Plc
7. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Pharmacotherapy
7.1 Overview
7.2 Global Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)
7.3 Mirabegron
7.3.1 Overview
7.3.2 Mirabegron Market Revenue and Forecast to 2028 (US$ Million)
7.4 Botox
7.4.1 Overview
7.4.2 Botox Market Revenue and Forecast to 2028 (US$ Million)
7.5 Neurostimulation
7.5.1 Overview
7.5.2 Neurostimulation Market Revenue and Forecast to 2028 (US$ Mn)
7.5.3 Transcutaneous Sacral Nerve Stimulation
7.5.3.1 Overview
7.5.3.2 Transcutaneous Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
7.5.4 Transcutaneous Tibial Nerve Stimulation
7.5.4.1 Overview
7.5.4.2 Transcutaneous Tibial Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
7.5.5 Percutaneous Posterior Tibial Nerve Stimulation
7.5.5.1 Overview
7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
7.5.6 Others
7.5.6.1 Overview
7.5.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Anticholinergics
7.6.1 Overview
7.6.2 Anticholinergics Market Revenue and Forecast to 2028 (US$ Million)
7.6.3 Solifenacin
7.6.3.1 Overview
7.6.3.2 Solifenacin Market Revenue and Forecast to 2028 (US$ Million)
7.6.4 Oxybutynin
7.6.4.1 Overview
7.6.4.2 Oxybutynin Market Revenue and Forecast to 2028 (US$ Million)
7.6.5 Fesoterodine
7.6.5.1 Overview
7.6.5.2 Fesoterodine Market Revenue and Forecast to 2028 (US$ Million)
7.6.6 Darifenacin
7.6.6.1 Overview
7.6.6.2 Darifenacin Market Revenue and Forecast to 2028 (US$ Million)
7.6.7 Tolterodine
7.6.7.1 Overview
7.6.7.2 Tolterodine Market Revenue and Forecast to 2028 (US$ Million)
7.6.8 Trospium
7.6.8.1 Overview
7.6.8.2 Trospium Market Revenue and Forecast to 2028 (US$ Million)
7.6.9 Other Anticholinergics
7.6.9.1 Overview
7.6.9.2 Other Anticholinergics Market Revenue and Forecast to 2028 (US$ Million)
7.7 Intravesical Instillation
7.7.1 Overview
7.7.2 Intravesical Instillation Market Revenue and Forecast to 2028 (US$ Mn)
8. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Disease Type
8.1 Overview
8.2 Global Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)
8.3 Idiopathic Overactive Bladder
8.3.1 Overview
8.3.2 Idiopathic Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Neurogenic Overactive Bladder
8.4.1 Overview
8.4.2 Neurogenic Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 – Geographical Analysis
9.1 North America: Overactive Bladder Treatment Market
9.1.1 Overview
9.1.2 North America: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.1.3.1 North America: Overactive Bladder Treatment Market, by Anticholinergics– Revenue and Forecast to 2028 (US$ Million)
9.1.3.2 North America: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)
9.1.4 North America: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)
9.1.5 North America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 US: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2 US: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2.1 US: Overactive Bladder Treatment Market, by Anticholinergics– Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2.2 US: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.3 US: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)
9.1.5.2 Canada: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 Canada: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2 Canada: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2.1 Canada: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2.2 Canada: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.3 Canada: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)
9.1.5.3 Mexico: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Mexico: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2 Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2.1 Mexico: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2.2 Mexico: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.3 Mexico: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)
9.2 Europe: Overactive Bladder Treatment Market
9.2.1 Overview
9.2.2 Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.2.3.1 Europe: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
9.2.3.2 Europe: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
9.2.4 Europe: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
9.2.5 Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
9.2.5.1 UK: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 UK: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.2 UK: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.2.1 UK: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.2.2 UK: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 UK: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2 Germany: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Germany: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.2 Germany: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.2.1 Germany: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.2.2 Germany: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 Germany: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3 France: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 France: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.2 France: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.2.1 France: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.2.2 France: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 France: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4 Italy: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Italy: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.2 Italy: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.2.1 Italy: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.2.2 Italy: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5 Spain: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Spain: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.2 Spain: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.2.1 Spain: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.2.2 Spain: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6 Rest of Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Rest of Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.2 Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.2.1 Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.2.2 Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
9.3 Asia Pacific: Overactive Bladder Treatment Market
9.3.1 Overview
9.3.2 Asia Pacific: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.3.3.1 Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.3.3.2 Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.3.4 Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.3.5 Asia Pacific: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: overactive bladder treatment Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.1.1 China: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.2 China: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.3.5.1.2.1 China: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.3.5.1.2.2 China Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.3.5.1.3 China: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.3.5.2 Japan: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.1 Japan: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.2 Japan: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.3.5.2.2.1 Japan: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.3.5.2.2.2 Japan Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.3.5.2.3 Japan: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.3.5.3 India: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.3.1 India: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.2 India: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.3.5.3.2.1 India: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.3.5.3.2.2 India Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.3.5.3.3 India: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.3.5.4 South Korea: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.1 South Korea: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.2 South Korea: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.3.5.4.2.1 South Korea: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.3.5.4.2.2 South Korea Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.3.5.4.3 South Korea: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.3.5.5 Australia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.1 Australia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.2 Australia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.3.5.5.2.1 Australia: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.3.5.5.2.2 Australia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.3.5.5.3 Australia: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.3.5.6 Rest of Asia Pacific: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Rest of Asia Pacific: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.2 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.3.5.6.2.1 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.3.5.6.2.2 Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.3.5.6.3 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.4 Middle East & Africa: Overactive Bladder Treatment Market
9.4.1 Overview
9.4.2 Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4.3 Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.4.3.1 Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.4.3.2 Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.4.4 Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.4.5 Middle East & Africa: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
9.4.5.1 UAE: overactive bladder treatment Market – Revenue and Forecast to 2028 (USD Million)
9.4.5.1.1 UAE: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.2 UAE: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.4.5.1.2.1 UAE: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.4.5.1.2.2 UAE Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.4.5.1.3 UAE: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.4.5.2 Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.1 Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.2 Saudi Arabia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.4.5.2.2.1 Saudi Arabia: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.4.5.2.2.2 Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.4.5.2.3 Saudi Arabia: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.4.5.3 South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.4.5.3.1 South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.2 South Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.4.5.3.2.1 South Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.4.5.3.2.2 South Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.4.5.3.3 South Africa: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.4.5.4 Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.2 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)
9.4.5.4.2.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.4.5.4.2.2 Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.4.5.4.3 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)
9.5 South and Central America: Overactive Bladder Treatment Market
9.5.1 Overview
9.5.2 South and Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.5.3 South and Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)
9.5.3.1 South and Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.5.3.2 South & Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.5.4 South and Central America: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)
9.5.5 South and Central America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
9.5.5.1 Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.5.5.2 Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.5.5.3 Brazil: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)
9.5.5.3.1.1 Brazil: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.5.5.3.1.2 Brazil Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.5.5.4 Brazil: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)
9.5.6 Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.5.6.1 Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.5.6.1.1 Argentina: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)
9.5.6.1.1.1 Argentina: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.5.6.1.1.2 Argentina Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.5.6.1.2 Argentina: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)
9.5.6.2 Rest of South and Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.5.6.2.1 Rest of South and Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.5.6.2.2 Rest of South and Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)
9.5.6.2.2.1 Rest of South and Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)
9.5.6.2.2.2 Rest of South & Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)
9.5.6.2.3 Rest of South and Central America: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Overactive Bladder Treatment Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 South & Central America: Impact Assessment of COVID-19 Pandemic
10.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11. Overactive Bladder Treatment Market– Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
12. Company Profiles
12.1 Alembic Pharmaceuticals Limited
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Astellas Pharma Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 AbbVie Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Teva Pharmaceutical Industries Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Endo Pharmaceuticals Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Hisamitsu Pharmaceutical Co.,Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Medtronic Plc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Colorado Urology Associates, PLLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Axonics Modulation Technologies, Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. US: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 6. US: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 7. US: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 8. US: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 24. UK: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 29. France: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 30. France: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 47. Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 49. China Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 50. China Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 51. China Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 52. China Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. Japan Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 54. Japan Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 57. India Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 58. India Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 59. India Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 60. India Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 61. South Korea Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 62. South Korea Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 63. South Korea Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 64. South Korea Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 65. Australia Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 66. Australia Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 67. Australia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 68. Australia Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 70. Rest of Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Asia Pacific Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 73. Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 74. Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 75. Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East & Africa Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 77. UAE Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 78. UAE Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 79. UAE Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 80. UAE Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 81. Saudi Arabia Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 82. Saudi Arabia Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 83. Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 84. Saudi Arabia Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 85. South Africa Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 86. South Africa Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 87. South Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 88. South Africa Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 91. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 93. South and Central America Overactive Bladder Treatment Market, by Pharmacotherapy– Revenue and Forecast to 2028 (USD Million)
Table 94. South and Central America Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 95. South and Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 96. South and Central America Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (USD Million)
Table 97. Brazil Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)
Table 98. Brazil Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 101. Argentina Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)
Table 102. Argentina Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of South and Central America Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of South and Central America Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South and Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South and Central America Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 109. Organic Developments Done by Companies
Table 110. Glossary of Terms
LIST OF FIGURES
Figure 1. Global Overactive Bladder Treatment Market Segmentation
Figure 2. Global Overactive Bladder Treatment Market Segmentation, By Region
Figure 3. Global Overactive Bladder Treatment Market Overview
Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in Overactive Bladder Treatment market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Overactive Bladder Treatment Market, By Geography (US$ Million)
Figure 7. Global Overactive Bladder Treatment Market – Leading Country Markets (US$ Million)
Figure 8. Global Overactive Bladder Treatment Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East & Africa: PEST Analysis
Figure 14. Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints
Figure 15. Global Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2021- 2028
Figure 17. Global Overactive Bladder Treatment Market – Market Potential Analysis, By Region
Figure 18. Analysis of Key Players in Overactive Bladder Treatment Market
Figure 19. Global Overactive Bladder Treatment Market – Comparative Company Analysis
Figure 20. Global Overactive Bladder Treatment Market – Growth Strategy Analysis
Figure 21. Global Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)
Figure 22. Mirabegron Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Botox Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Neurostimulation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Transcutaneous Sacral Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
Figure 26. Transcutaneous Tibial Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
Figure 27. Percutaneous Posterior Tibial Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
Figure 28. Others Market Revenue and Forecasts To 2028 (US$ MN)
Figure 29. Anticholinergics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Solifenacin Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Oxybutynin Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Fesoterodine Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Darifenacin Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Tolterodine Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Trospium Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Other Anticholinergics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Intravesical Instillation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. Global Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)
Figure 39. Idiopathic Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. Neurogenic Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 41. North America: Overactive Bladder Treatment Market Revenue Overview, By Key Country – Revenue (2021) (US$ Million)
Figure 42. North America: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
Figure 43. North America: Overactive Bladder Treatment Market, By Country, 2021 & 2028 (%)
Figure 44. US: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
Figure 45. Canada: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
Figure 46. Mexico: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
Figure 47. Europe: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 48. Europe: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 49. Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
Figure 50. UK: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Germany: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. France: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Italy: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Spain: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Rest of Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Asia Pacific: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 57. Asia Pacific Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 58. China: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Japan: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. India: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. South Korea: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Australia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. Rest of Asia Pacific: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Middle East & Africa: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 65. Middle East & Africa Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 66. UAE: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 67. Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 69. Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. South and Central America: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (USD Million)
Figure 71. South and Central America Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 72. Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 73. Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. Rest of South and Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 75. Impact of COVID-19 Pandemic on North American Country Markets
Figure 76. Impact of COVID-19 Pandemic in European Countries Markets
Figure 77. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 78. Impact of COVID-19 Pandemic on South and Central America Country Markets
Figure 79. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 80. Growth Strategies Done by the Companies in the Market, (%)
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the overactive bladder treatment market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global overactive bladder treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the overactive bladder treatment market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
The List of Companies – Overactive Bladder Treatment Market
1. Alembic Pharmaceuticals Limited
2. Astellas Pharma Inc
3. Pfizer Inc
4. AbbVie Inc
5. Teva Pharmaceutical Industries Ltd
6. Endo Pharmaceuticals Inc.
7. Hisamitsu Pharmaceutical Co.,Inc
8. Medtronic Plc
9. Colorado Urology Associates, PLLC
10. Axonics Modulation Technologies, Inc
Neurostimulation to Register Fastest CAGR in Overactive Bladder Treatment Market During 2022–2028
According to our latest study on “Overactive Bladder Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Pharmacotherapy and Disease Type,” the market is projected to reach US$ 5,333.92 million by 2028 from US$ 4,295.93 million in 2021; it is expected to grow at a CAGR of 3.1% from 2022 to 2028. The report highlights the key factors driving the market and prominent players with their developments in the market.
The overactive bladder treatment market witnessed growth due to increased overactive bladder symptoms observed in COVID-19-recovered patients. COVID-19 virus not only affected the respiratory tract of the body, but it also affected the bladder of the patient. Further, COVID-19 infection resulted in urine cytokine elevation that increased urination frequency, leading to overactive bladder disorder among COVID-19 patients. According to a study by American Urological Association, patients with COVID-19 infections were at an increased risk for developing new or worsening overactive bladder symptoms. Moreover, approximately one-third of patients with COVID-19 reported a significant increase in clinical symptoms during the International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB) conducted two months after infection.
Based on pharmacotherapy, the overactive bladder treatment market is segmented into anticholinergics, mirabegron, botox, intravesical instillation, and neurostimulation. The neurostimulation segment is further segmented into transcutaneous sacral nerve stimulation, transcutaneous tibial nerve stimulation, percutaneous posterior tibial nerve stimulation, and others. The anticholinergics segment is further segmented into solifenacin, oxybutynin, fesoterodine, darifenacin, tolterodine, trospium, and other anticholinergics. The mirabegron segment held the largest share of the market in 2021, and the neurostimulation segment is anticipated to register the highest CAGR in the market during the forecast period. Based on disease type, the overactive bladder treatment market is bifurcated into idiopathic overactive bladder and neurogenic overactive bladder. The idiopathic overactive bladder segment held a larger market share in 2021, and it is also anticipated to register a higher CAGR in the market during the forecast period.
Urinary incontinence is the loss of bladder control caused due to the improper functioning of the muscles and nerves that control the passage of urine through the bladder. According to the National Association for Incontinence data, in 2018, ~200 million people worldwide were affected by urinary incontinence. Stress incontinence and urge incontinence are the two common types of urinary incontinence affecting women, wherein the latter is also known as overactive bladder. As per the data provided by Office on Women’s Health a division of the US Department of Health and Human Services, the prevalence of incontinence in women is twice as in men, and aging, pregnancy, childbirth, and menopause can be the key factors leading to this condition in women. Other factors affecting the function of muscles and nerves include being overweight, constipation, or pelvic surgeries. As stated by the North American Menopause Society (NAMS), in the US, the prevalence of urinary incontinence was 17.1% among women aged 20 years or more and 38% in women aged 60 years and older in 2021. Although urinary incontinence may affect women at any age, it is more common in older women, mainly due to hormonal changes during menopause. According to the National Health Service (NHS), ~4 in every ten women aged 65 and older have urinary incontinence. As per the HCA UK (a healthcare provider), ~3 million people in the UK are affected by urinary incontinence, of which 15% of women and ~5% of men are in their mid-40s. Thus, the growing prevalence of urinary incontinence favors the growth of the overactive bladder treatment market.
Alembic Pharmaceuticals Limited; Astellas Pharma Inc; Pfizer Inc.; AbbVie Inc; Teva Pharmaceutical Industries Ltd; Endo Pharmaceuticals Inc.; Hisamitsu Pharmaceutical Co.Inc; Medtronic Plc; Allergan; and Colorado Urology Associates, PLLC are among the leading companies operating in the overactive bladder treatment market.
Overactive Bladder Treatment Market, by Region, 2021 (%)
Source: The Insight Partners Analysis
In terms of geography, the overactive bladder treatment market has been segmented as follows:
Based on geography, the overactive bladder treatment market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa (MEA), and South & Central America. The market in North America is further segmented into the US, Canada, and Mexico. The European market is subsegmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The overactive bladder treatment market in APAC is segmented into Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific. The overactive bladder treatment market in the MEA is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East& AFrica. The market in South & Central America is further segmented into Brazil, Argentina, and the Rest of South & Central America.
Related Reports
- $3,000.00 – $5,000.00
